INDO US BIOTECH
Back to All Ratios
|
INDO US BIOTECH Last 5 Year Return on Capital Employed (ROCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 21.15 | 14.42 | 14.62 | 15.86 | 18.30 |
What is the latest Return on Capital Employed (ROCE) ratio of INDO US BIOTECH ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 21.15 |
| Mar2024 | 14.42 |
| Mar2023 | 14.62 |
| Mar2022 | 15.86 |
| Mar2021 | 18.30 |
How is Return on Capital Employed (ROCE) of INDO US BIOTECH Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 21.15 | 46.67 | |
| Mar2024 | 14.42 | -1.37 | |
| Mar2023 | 14.62 | -7.82 | |
| Mar2022 | 15.86 | -13.33 | |
| Mar2021 | 18.3 | - | |
Other Financial Ratios of INDO US BIOTECH
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹261.1 Cr | -5.2% | -3.4% | -50% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,503.7 Cr | -2.3% | 4.9% | -28.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,140.1 Cr | -3.1% | -6.8% | 7.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,916.2 Cr | -11.3% | -8.8% | -23.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,252.1 Cr | -1.2% | -2.5% | -27.1% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹458.1 Cr | -1.5% | -18.8% | 10.6% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -5.2% |
-3.4% |
-50% |
| SENSEX | -0.5% |
2% |
4.8% |
You may also like the below Video Courses